Literature DB >> 26482308

Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.

Hui Zhang1, Qiwen Yang1, Kang Liao2, Yuxing Ni3, Yunsong Yu4, Bijie Hu5, Ziyong Sun6, Wenxiang Huang7, Yong Wang8, Anhua Wu9, Xianju Feng10, Yanping Luo11, Zhidong Hu12, Yunzhuo Chu13, Shulan Chen14, Bin Cao15, Jianrong Su16, Bingdong Gui17, Qiong Duan18, Shufang Zhang19, Haifeng Shao20, Haishen Kong21, Robert E Badal22, Yingchun Xu23.   

Abstract

To evaluate the antimicrobial susceptibility of Gram-negative bacilli that caused hospital-acquired and community-acquired intra-abdominal infections (IAIs) in China between 2012 and 2013, we determined the susceptibilities to 12 antimicrobials and the extended-spectrum β-lactamase (ESBL) statuses of 3,540 IAI isolates from seven geographic areas in China in a central laboratory using CLSI broth microdilution and interpretive standards. Most infections were caused by Escherichia coli (46.3%) and Klebsiella pneumoniae (19.7%). Rates of ESBL-producing E. coli (P = 0.031), K. pneumoniae (P = 0.017), and Proteus mirabilis (P = 0.004) were higher in hospital-acquired IAIs than in community-acquired IAIs. Susceptibilities of enterobacteriaceae to ertapenem, amikacin, piperacillin-tazobactam, and imipenem were 71.3% to 100%, 81.3% to 100%, 64.7% to 100%, and 83.1% to 100%, respectively, but imipenem was ineffective against P. mirabilis (<20%). Although most ESBL-positive hospital-acquired isolates were resistant to third- and fourth-generation cephalosporins, the majority were susceptible to cefoxitin (47.9% to 83.9%). Susceptibilities of ESBL-positive isolates to ampicillin-sulbactam (<10%) were low, whereas susceptibilities to ciprofloxacin (0% to 54.6%) and levofloxacin (0% to 63.6%) varied substantially. The prevalences of cephalosporin-susceptible E. coli and K. pneumoniae were higher in the northeastern and southern regions than in the central and eastern regions, reflecting the ESBL-positive rates in these areas, and were lowest in the Jiangsu-Zhejiang (Jiang-Zhe) area where the rates of carbapenem resistance were also highest. Ertapenem, amikacin, piperacillin-tazobactam, and imipenem are the most efficacious antibiotics for treating IAIs in China, especially those caused by E. coli or K. pneumoniae. Resistance to cephalosporins and carbapenems is more common in the Jiang-Zhe area than in other regions in China.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26482308      PMCID: PMC4704199          DOI: 10.1128/AAC.00956-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

Review 1.  Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs).

Authors:  D L Paterson
Journal:  Clin Microbiol Infect       Date:  2000-09       Impact factor: 8.067

2.  Surveillance of antimicrobial susceptibility of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in China: the 2002-2009 Study for Monitoring Antimicrobial Resistance Trends (SMART).

Authors:  Qiwen Yang; Hui Wang; Minjun Chen; Yuxing Ni; Yunsong Yu; Bijie Hu; Ziyong Sun; Wenxiang Huang; Yunjian Hu; Huifen Ye; Robert E Badal; Yingchun Xu
Journal:  Int J Antimicrob Agents       Date:  2010-10-30       Impact factor: 5.283

Review 3.  Empiric treatment options in the management of complicated intra-abdominal infections.

Authors:  John A Weigelt
Journal:  Cleve Clin J Med       Date:  2007-08       Impact factor: 2.321

4.  Antimicrobial susceptibility of Gram-negative bacteria causing intra-abdominal infections in China: SMART China 2011.

Authors:  Hui Zhang; Qiwen Yang; Meng Xiao; Minjun Chen; Robert E Badal; Yingchun Xu
Journal:  Chin Med J (Engl)       Date:  2014       Impact factor: 2.628

5.  Effect of initial empiric antibiotic therapy combined with control of the infection focus on the prognosis of patients with secondary peritonitis.

Authors:  Estela Membrilla-Fernández; Juan J Sancho-Insenser; Meritxell Girvent-Montllor; Francisco Álvarez-Lerma; Antonio Sitges-Serra
Journal:  Surg Infect (Larchmt)       Date:  2014-12       Impact factor: 2.150

6.  The epidemiology of sepsis in general surgery patients.

Authors:  Laura J Moore; Bruce A McKinley; Krista L Turner; S Rob Todd; Joseph F Sucher; Alicia Valdivia; R Matthew Sailors; Lillian S Kao; Frederick A Moore
Journal:  J Trauma       Date:  2011-03

7.  Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.

Authors:  D M Livermore; K J Oakton; M W Carter; M Warner
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

Review 8.  High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece--a review of the current evidence.

Authors:  A Vatopoulos
Journal:  Euro Surveill       Date:  2008-01-24

Review 9.  The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.

Authors:  Patrice Nordmann; Gaelle Cuzon; Thierry Naas
Journal:  Lancet Infect Dis       Date:  2009-04       Impact factor: 25.071

10.  Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America.

Authors:  Joseph S Solomkin; John E Mazuski; John S Bradley; Keith A Rodvold; Ellie J C Goldstein; Ellen J Baron; Patrick J O'Neill; Anthony W Chow; E Patchen Dellinger; Soumitra R Eachempati; Sherwood Gorbach; Mary Hilfiker; Addison K May; Avery B Nathens; Robert G Sawyer; John G Bartlett
Journal:  Clin Infect Dis       Date:  2010-01-15       Impact factor: 9.079

View more
  9 in total

1.  Clinical and Microbiological Characteristics of Patients with Complicated Intra-abdominal Infections in Intensive Care Unit.

Authors:  Yang-Mei Xiong; Xin Rao
Journal:  Curr Med Sci       Date:  2020-03-13

2.  Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).

Authors:  Giulia De Angelis; Barbara Fiori; Giulia Menchinelli; Tiziana D'Inzeo; Flora Marzia Liotti; Grazia Angela Morandotti; Maurizio Sanguinetti; Brunella Posteraro; Teresa Spanu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-06-09       Impact factor: 3.267

3.  Effect of multiple drug resistance on total medical costs among patients with intra-abdominal infections in China.

Authors:  Xuemei Zhen; Yuanyuan Li; Yixi Chen; Peng Dong; Stephanie Liu; Hengjin Dong
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

4.  Shifting trends in bacteriology and antimicrobial resistance among gastrointestinal fistula patients in China: an eight-year review in a tertiary-care hospital.

Authors:  Qinjie Liu; Jianan Ren; Xiuwen Wu; Gefei Wang; Zhiwei Wang; Jie Wu; Jinjian Huang; Tianyu Lu; Jieshou Li
Journal:  BMC Infect Dis       Date:  2017-09-21       Impact factor: 3.090

5.  Analysis of Susceptibilities of Carbapenem Resistant Enterobacterales to Colistin in Intra-Abdominal, Respiratory and Urinary Tract Infections from 2015 to 2017.

Authors:  Hui Zhang; Jingjia Zhang; Yue Kang; Qiwen Yang; Yingchun Xu
Journal:  Infect Drug Resist       Date:  2020-06-23       Impact factor: 4.003

6.  Antimicrobial Susceptibility of Microorganisms Isolated from Patients with Intraabdominal Infection in Korea: a Multicenter Study.

Authors:  Young Kyung Yoon; Jieun Kim; Chisook Moon; Mi Suk Lee; Jian Hur; Hojin Lee; Shin Woo Kim
Journal:  J Korean Med Sci       Date:  2019-12-09       Impact factor: 2.153

7.  Genetic diversity and multidrug resistance of phylogenic groups B2 and D in InPEC and ExPEC isolated from chickens in Central China.

Authors:  Qin Lu; Wenting Zhang; Ling Luo; Honglin Wang; Huabin Shao; Tengfei Zhang; Qingping Luo
Journal:  BMC Microbiol       Date:  2022-02-18       Impact factor: 3.605

8.  The efficacy and safety of eravacycline compared with current clinically common antibiotics in the treatment of adults with complicated intra-abdominal infections: A Bayesian network meta-analysis.

Authors:  Rui Meng; Xin Guan; Lei Sun; Zhengyang Fei; Yuxin Li; Mengjie Luo; Aixia Ma; Hongchao Li
Journal:  Front Med (Lausanne)       Date:  2022-09-16

9.  Antimicrobial susceptibility changes of Escherichia coli and Klebsiella pneumoniae intra-abdominal infection isolate-derived pathogens from Chinese intra-abdominal infections from 2011 to 2015.

Authors:  Hui Zhang; Dawei Tong; Aaron Johnson; Ge Zhang; Zhipeng Xu; Yang Yang; Jingjia Zhang; Dongxue Li; Simeng Duan; Yao Wang; Qiwen Yang; Yingchun Xu
Journal:  Infect Drug Resist       Date:  2019-08-09       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.